Welcome to our dedicated page for The Cooper Companies news (Ticker: $COO), a resource for investors and traders seeking the latest updates and insights on The Cooper Companies stock.
The Cooper Companies, Inc. (NYSE: COO) is a global medical device company specializing in improving quality of life through innovative products and services. Headquartered in San Ramon, CA, Cooper operates through two main business units: CooperVision and CooperSurgical.CooperVision is a leader in the contact lens industry, offering a diverse range of high-quality contact lenses, including spherical, multifocal, toric, and specialty lenses. With brands like Proclear, Biofinity, MyDay, and Clariti, CooperVision commands roughly one-fourth of the US contact lens market. The company is committed to providing excellent practitioner support, ensuring that both users and professionals benefit from their cutting-edge solutions.
CooperSurgical, founded in 1990, focuses on women's health and fertility, offering market-leading products and treatment options. The division supplies clinicians with over 600 medical devices and treatment solutions related to reproductive care, fertility, and women's health. Notably, CooperSurgical owns Paragard, the only hormone-free IUD available in the US, holding a 17% share of the US IUD market. Additionally, CooperSurgical has the largest medical device coverage for the entire IVF cycle.
With a workforce of over 15,000 employees and products available in more than 130 countries, CooperCompanies is dedicated to delivering shareholder value while enhancing the lives of individuals globally. The company continues to innovate and expand, recently achieving record annual revenues and strong earnings. Noteworthy advancements include a four-for-one stock split set to become effective on February 16, 2024, and partnerships like that with Fulgent Genetics to offer exclusive newborn genetic screening panels through Cord Blood Registry.
Cooper's fiscal year 2023 showcased significant milestones, including double-digit organic growth in their fertility segment and strong performance in contact lenses. As they move into fiscal year 2024, Cooper remains focused on their strategic objectives: gaining market share, driving profitability, and launching innovative products and services.
For more information, please visit CooperCompanies.
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.87%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.67%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.44%
Tags
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.58%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.14%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.04%
Tags
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.35%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.18%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.11%
Tags
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.03%
Tags
FAQ
What does The Cooper Companies, Inc. specialize in?
The Cooper Companies, Inc. specializes in medical devices through its two business units, CooperVision and CooperSurgical. CooperVision focuses on contact lenses, while CooperSurgical offers products related to fertility and women's health.
Where is The Cooper Companies, Inc. headquartered?
The Cooper Companies, Inc. is headquartered in San Ramon, California.
What are some of CooperVision's popular contact lens brands?
CooperVision's popular contact lens brands include Proclear, Biofinity, MyDay, and Clariti.
What makes CooperSurgical unique in the women's health market?
CooperSurgical is unique for its comprehensive range of products covering the entire IVF cycle and for being the only provider of the hormone-free IUD, Paragard, in the US.
How many employees does The Cooper Companies, Inc. have?
The Cooper Companies, Inc. employs more than 15,000 people globally.
What recent financial achievements has CooperCompanies reported?
CooperCompanies reported record annual revenues for fiscal year 2023, driven by gains in contact lenses and fertility. They also announced a four-for-one stock split effective February 16, 2024.
In how many countries are CooperCompanies’ products available?
CooperCompanies’ products are available in over 130 countries.
What recent partnerships has CooperSurgical announced?
CooperSurgical recently partnered with Fulgent Genetics to offer exclusive newborn genetic screening panels through Cord Blood Registry.
What are CooperCompanies' strategic objectives for fiscal year 2024?
CooperCompanies' strategic objectives for fiscal year 2024 include gaining market share, driving profitability, and launching innovative products and services.
Where can I find more information about The Cooper Companies, Inc.?
For more information about The Cooper Companies, Inc., please visit their official website at www.coopercos.com.
The Cooper Companies, Inc.
NYSE:COO
COO Rankings
COO Stock Data
18.61B
197.47M
0.54%
100.45%
1.1%
Surgical Appliance and Supplies Manufacturing
Manufacturing
United States of America
SAN RAMON